Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review

OP0296 THE 2021 DORIS DEFINITION OF REMISSION IN SLE – FINAL RECOMMENDATIONS FROM AN INTERNATIONAL TASK FORCE

(2021) R. van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline

(2020) Mhairi Campbell et al.   BMJ-British Medical Journal

Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort

(2020) Francesca Saccon et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of three different definitions of low disease activity in patients with systemic lupus erythematosus and their prognostic utilities

(2020) Ji-Hyoun Kang et al.   RHEUMATOLOGY

Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment

(2020) J. Jakez-Ocampo et al.   CLINICAL RHEUMATOLOGY

Long‐term remission in patients with systemic lupus erythematosus

(2020) Mozhdeh Nikfar et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Achieving Lupus Low Disease Activity State (LLDAS-50) is associated with both reduced damage accrual and mortality in patients with Systemic Lupus Erythematosus

(2019) Chanakya Sharma et al.   ARTHRITIS CARE & RESEARCH

Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort

(2019) G.S. Alarcón et al.   LUPUS

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a multi-ethnic, multinational Latin-American Lupus Cohort

(2019) Manuel F. Ugarte-Gil et al.   JOURNAL OF RHEUMATOLOGY

Quality of life among female patients with systemic lupus erythematosus in remission

(2019) Rudra Prosad Goswami et al.   RHEUMATOLOGY INTERNATIONAL

Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus

(2019) N Poomsalood et al.   LUPUS

Low Disease Activity State/Remission Predicts a Better Health‐Related Quality of Life in Systemic Lupus Erythematosus Patients

(2019) Manuel F. Ugarte‐Gil et al.   ARTHRITIS CARE & RESEARCH

Lupus Low Disease Activity State is Associated with Reduced Direct Healthcare Costs in Patients with Systemic Lupus Erythematosus

(2019) Ai Li Yeo et al.   ARTHRITIS CARE & RESEARCH

Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse

(2019) Alexis Mathian et al.   ANNALS OF THE RHEUMATIC DISEASES

Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients

(2019) C Reátegui-Sokolova et al.   LUPUS

Predictors of predominant Lupus Low Disease Activity State (LLDAS-50)

(2019) H Babaoglu et al.   LUPUS

The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus

(2019) D P E Margiotta et al.   LUPUS

Treatment target in newly diagnosed Systemic Lupus Erythematosus

(2019) Alberto Floris et al.   ARTHRITIS CARE & RESEARCH

Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort

(2018) Michelle Petri et al.   Arthritis & Rheumatology

Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study

(2018) Serena Fasano et al.   CLINICAL RHEUMATOLOGY

Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions

(2018) Claudia Elera-Fitzcarrald et al.   Expert Review of Clinical Immunology

New therapeutic strategies in systemic lupus erythematosus management

(2018) Mariele Gatto et al.   Nature Reviews Rheumatology

The relationship between remission and health-related quality of life in a cohort of SLE patients

(2018) Michel W P Tsang-A-Sjoe et al.   RHEUMATOLOGY

Defining Low Disease Activity in Systemic Lupus Erythematosus

(2017) Ari Polachek et al.   ARTHRITIS CARE & RESEARCH

Remission in systemic lupus erythematosus: durable remission is rare

(2016) Theresa R Wilhelm et al.   ANNALS OF THE RHEUMATIC DISEASES

The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients

(2016) Margherita Zen et al.   ANNALS OF THE RHEUMATIC DISEASES

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

(2016) Ronald van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus

(2016) Michel W. P. Tsang-A-Sjoe et al.   RHEUMATOLOGY

Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period

(2016) Carmen V. Medina-Quiñones et al.   ARTHRITIS CARE & RESEARCH

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)

(2015) Kate Franklyn et al.   ANNALS OF THE RHEUMATIC DISEASES